@ahjay, why would they have released this after 4, rather than just before trading tomorrow?
i read it as positive for progress, is this how you see it?
is the data strong enough to be attractive to big pharma or do you think they will prefer to see phase 2 in your opinion?
Ann: Immutep presents new TACTI-mel data at ICI Europe Summit, page-11
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $407.2M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.3¢ | $158.9K | 572.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 263716 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 43176 | 3 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |